Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Acta Neurol Belg ; 121(6): 1519-1523, 2021 Dec.
Article in English | MEDLINE | ID: mdl-32436077

ABSTRACT

Since 2015, edaravone is the second drug available for the treatment of Amyotrophic lateral sclerosis (ALS). In this study we analyzed the characteristics and experience of ALS patients treated with this new medication in our country. Sixteen ALS patients were treated with edaravone infusions in three ALS clinics. Most of them were male, had a spinal onset of the disease and a definite diagnosis of ALS. Mean age at first infusion was 53.5 years. Since the diagnosis of ALS, delay in starting treatment with edaravone was five times greater than that of riluzole. Edaravone therapy was usually initiated at a health care facility and was followed by domiciliary cycles. Adverse effects and the need of a special catheter for infusion were rare. Access to edaravone through health insurance was possible in only 43.8% of patients. Altogether, treatment access was limited but feasible and edaravone was well tolerated.


Subject(s)
Amyotrophic Lateral Sclerosis/drug therapy , Amyotrophic Lateral Sclerosis/epidemiology , Edaravone/administration & dosage , Neuroprotective Agents/administration & dosage , Adult , Aged , Argentina/epidemiology , Drug Administration Routes , Female , Humans , Male , Middle Aged
2.
Am J Gastroenterol ; 112(1): 120-131, 2017 01.
Article in English | MEDLINE | ID: mdl-27958281

ABSTRACT

OBJECTIVES: The aims of this study were to assess the risk of relapse after discontinuation of anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory bowel disease (IBD), to identify the factors associated with relapse, and to evaluate the overcome after retreatment with the same anti-TNF in those who relapsed. METHODS: This was a retrospective, observational, multicenter study. IBD patients who had been treated with anti-TNFs and in whom these drugs were discontinued after clinical remission was achieved were included. RESULTS: A total of 1,055 patients were included. The incidence rate of relapse was 19% and 17% per patient-year in Crohn's disease and ulcerative colitis patients, respectively. In both Crohn's disease and ulcerative colitis patients in deep remission, the incidence rate of relapse was 19% per patient-year. The treatment with adalimumab vs. infliximab (hazard ratio (HR)=1.29; 95% confidence interval (CI)=1.01-1.66), elective discontinuation of anti-TNFs (HR=1.90; 95% CI=1.07-3.37) or discontinuation because of adverse events (HR=2.33; 95% CI=1.27-2.02) vs. a top-down strategy, colonic localization (HR=1.51; 95% CI=1.13-2.02) vs. ileal, and stricturing behavior (HR=1.5; 95% CI=1.09-2.05) vs. inflammatory were associated with a higher risk of relapse in Crohn's disease patients, whereas treatment with immunomodulators after discontinuation (HR=0.67; 95% CI=0.51-0.87) and age (HR=0.98; 95% CI=0.97-0.99) were protective factors. None of the factors were predictive in ulcerative colitis patients. Retreatment of relapse with the same anti-TNF was effective (80% responded) and safe. CONCLUSIONS: The incidence rate of inflammatory bowel disease relapse after anti-TNF discontinuation is relevant. Some predictive factors of relapse after anti-TNF withdrawal have been identified. Retreatment with the same anti-TNF drug was effective and safe.


Subject(s)
Adalimumab/therapeutic use , Antirheumatic Agents/therapeutic use , Colitis, Ulcerative/drug therapy , Crohn Disease/drug therapy , Deprescriptions , Immunologic Factors/therapeutic use , Infliximab/therapeutic use , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Colitis, Ulcerative/physiopathology , Colon , Constriction, Pathologic , Crohn Disease/physiopathology , Disease Progression , Drug-Related Side Effects and Adverse Reactions , Female , Follow-Up Studies , Humans , Ileum , Incidence , Inflammatory Bowel Diseases/drug therapy , Male , Mesalamine/therapeutic use , Methotrexate/therapeutic use , Middle Aged , Proportional Hazards Models , Protective Factors , Recurrence , Remission Induction , Retreatment , Retrospective Studies , Risk Factors , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Young Adult
3.
Acta Neurol Scand ; 123(1): 60-7, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20545634

ABSTRACT

UNLABELLED: Negative prognostic factors in amyotrophic lateral sclerosis include advanced age, shorter time from disease onset to diagnosis, bulbar onset and rapid progression rate. OBJECTIVE: To compare progesterone (PROG) and cortisol serum levels in patients and controls and ascertain its relationship to prognostic factors and survival. METHODS: We assessed serum hormonal levels in 27 patients and 21 controls. RESULTS: Both hormones were 1.4-fold higher in patients. PROG showed a negative correlation with age, positive correlation with survival and positive trend with time to diagnosis. Increased PROG was observed in spinal onset and slow progression patients. No correlation was demonstrated with cortisol. CONCLUSION: Increased hormonal levels in patients are probably due to hypothalamic-pituitary-adrenal axis activation. Nevertheless, in this preliminary report only PROG correlated positively with factors predicting better prognosis and survival. We hypothesize endogenous PROG and cortisol may be engaged in differential roles, the former possibly involved in a neuroprotective response.


Subject(s)
Amyotrophic Lateral Sclerosis/blood , Amyotrophic Lateral Sclerosis/diagnosis , Progesterone/blood , Amyotrophic Lateral Sclerosis/mortality , Analysis of Variance , Case-Control Studies , Female , Humans , Hydrocortisone/blood , Male , Middle Aged , Prognosis , Radioimmunoassay/methods , Statistics as Topic
6.
Rev Neurol ; 36(2): 104-8, 2003.
Article in Spanish | MEDLINE | ID: mdl-12589593

ABSTRACT

INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a progressive degenerative disease involving motor neurons of the spinal cord, brain stem, and motor cortex. Previous studies reported the coexistence of motor neuron disease with thyroid dysfunction and primary hyperparathyroidism. These findings suggested an eventual role of the previously mentioned endocrine disorders and the development of ALS. OBJECTIVE: Identify thyroid dysfunction and changes in mineral metabolism in patients affected by sporadic ALS. PATIENTS AND METHODS: We retrospectively analyzed data from 41 in ward patients from June 1998, to June 2001. All of them were diagnosed with sporadic ALS. The following laboratory test were performed: thyrotropin (TSH), thyroxine (T4), serum calcium, serum phosphate, parathyroid hormone (PTH) and ionic calcium concentrations. RESULTS: None of the studied patients was found to be hyperthyroid. Two patients had elevated TSH and normal T4, these findings suggested subclinical hypothyroidism. Elevated PTH was found in one patient; another had primary hyperparathyroidism. Low serum calcium was found in three patients and elevated phosphate was found in another four. CONCLUSIONS: All these findings do not allow us to assert a pathogenic association between thyroid dysfunction or alteration of phosphate calcium metabolism and ALS.


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , Calcium/blood , Phosphates/blood , Thyroid Gland/metabolism , Adolescent , Adult , Aged , Amyotrophic Lateral Sclerosis/physiopathology , Female , Humans , Male , Middle Aged , Parathyroid Hormone/blood , Retrospective Studies , Thyroid Gland/physiopathology , Thyrotropin/blood , Thyroxine/blood
8.
Biochem Mol Med ; 57(2): 152-5, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8733894

ABSTRACT

To test whether the peripheral macrophage functions as early index of oxygen free radical release in association with the development of IgA nephropathy (IgAN), we studied female Lewis rats. IgAN was produced by treatment over 8 weeks with 0.1% bovine gamma globulin (BGG) in drinking water, followed by three daily intravenous injections of BGG, 1 mg/dose. Fifteen rats were divided randomly into three groups: control, IgAN, and IgAN fed vitamin E 100 IU/kg chow. At the end of the treatment period, rats were placed in individual metabolic cages for 24-h urine collections and then anesthetized with Inactin (100 mg/kg BW) for aspiration of peritoneal macrophages. The results (mean +/- SD) extended our previous data in male rats, confirming that the elevated proteinuria of IgAN (3.62 +/- 0.79 mg/day) was significantly reduced with vitamin E treatment (2.59 +/- 0.28 mg/day) in female rats (P < 0.002) More importantly, we indicated for the first time that oxygen free radicals production by peritoneal macrophages in IgAN was significantly reduced by vitamin E: 1.58 +/- 0.91 nmol/10(6) cells/15 min in the untreated group vs 3.28 +/- 0.54 nmol/10(6) cells/15 min in the vitamin E-treated group (P < 0.05).


Subject(s)
Glomerulonephritis, IGA/physiopathology , Macrophages, Peritoneal/physiology , Superoxides/metabolism , Animals , Cattle , Cells, Cultured , Female , Glomerulonephritis, IGA/immunology , Glomerulonephritis, IGA/urine , Kinetics , Macrophages, Peritoneal/drug effects , Male , Proteinuria , Rats , Rats, Inbred Lew , Reference Values , Vitamin E/pharmacology , gamma-Globulins/administration & dosage
9.
Bol Med Hosp Infant Mex ; 49(9): 581-4, 1992 Sep.
Article in Spanish | MEDLINE | ID: mdl-1388782

ABSTRACT

The objective for this work was to describe the transmission mechanisms and the clinical behavior of 60 HIV-infected pediatric patients. We studied children from newborn to 15 years old according to the CDC criteria. From January 1985 to February 1992, were evaluated 60 patients, 40 males and 20 females; 25 with perinatal transmission (23 transplacental and 2 breast-feeding), 22 hemophiliacs, 12 by blood transfusion and 1 by intramuscular injection with contaminated needle. The disease was symptomatic in 50 patients, asymptomatic in 5 and indeterminate in 5 cases. Up to date, 28 children are in phase P2, 10 in P0 and P1, and 22 patients have died. The clinical manifestations in 50 patients were: altered growth and development in 50, generalized lymphadenopathy in 30, severe infections in 23, fever in 15, hepatosplenomegaly in 15, chronic diarrhea in 10, and HIV-encephalopathy in one. It is concluded what at present time perinatal transmission is the main mechanism.


Subject(s)
Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/physiopathology , Acquired Immunodeficiency Syndrome/transmission , Adolescent , Child , Child, Preschool , Female , Hospitals, Public , Humans , Infant , Infant, Newborn , Male , Mexico/epidemiology
10.
Transfusion ; 30(6): 528-31, 1990.
Article in English | MEDLINE | ID: mdl-2165644

ABSTRACT

The immunoglobulin G subclass responses to cytomegalovirus (CMV) after red cell (RBC) transfusion were studied in 26 seropositive surgery patients and 34 transfused seropositive oncology patients. Also included as controls were 18 surgical patients who received no RBCs during surgery. None of the 78 patients studied had IgG2 to CMV before or after transfusion. The absence of a total IgG response to CMV after transfusion could not be attributed to preexisting deficiencies in one or more subclasses, because all 78 patients had similar levels of IgG1, IgG3, and IgG4 to CMV before transfusion. Discriminant analysis was used for statistical evaluation of the combined CMV subclass responses in each patient and the individual subclass responses. Individual patients responded to CMV antigens with an increase in concentration in any of the three subclasses or any combination of the subclasses, excluding IgG2. IgG subclass analysis showed that 10 of 27 patients who did not respond with at least a fourfold total IgG titer rise had a significant increase in IgG subclass antibodies to CMV. Three of 33 patients with at least a fourfold total IgG titer rise lacked a subclass response. These results suggest that the measurement of IgG subclasses may be a sensitive indicator of immune response to CMV.


Subject(s)
Antibodies, Viral/immunology , Cytomegalovirus/immunology , Antibody Formation , Blood Transfusion , Cardiac Surgical Procedures , Humans , Immunoglobulin G/immunology
11.
Ann Allergy ; 61(6): 428-32, 1988 Dec.
Article in English | MEDLINE | ID: mdl-3202333

ABSTRACT

Demographic information, symptoms, and allergy skin test data from 809 patients from four allergy practices (A, B, C, and D) were statistically evaluated. A panel of 42 allergens were used for a total of 24,293 tests. Allergen positivity ranged from 51% for house dust to 9% for cat/dog. The patient population had primarily respiratory tract spring symptoms. Significant differences between the practices were found for (1) the number of skin tests done per patient, (2) the number of positive tests per patient, and (3) the grading of a positive test. A patient had a 3-fold to 6-fold greater chance of being found atopic by practice C or D than by practice A with practice B being intermediate. These differences highlight the need for less variation and better diagnostic standardization in the practice of allergy.


Subject(s)
Hypersensitivity/diagnosis , Skin Tests/methods , Allergens/administration & dosage , Evaluation Studies as Topic , Humans
12.
Prim Care ; 14(3): 447-55, 1987 Sep.
Article in English | MEDLINE | ID: mdl-2890176

ABSTRACT

The diagnosis of allergic disease has to be individualized to each patient. In general, it consists of a good clinical history, a physical examination, and identification of specific relevant allergies by both in vitro and in vivo tests. These will contribute to an assessment of the patient's clinical status and severity of disease. One must always be aware that nonallergic mechanisms can also trigger an attack in atopic individuals. These are clinically indistinguishable from those provoked by an allergen-IgE immune response. We predict that the computer and accurate in vitro tests will join us in our offices. Before the end of this century, this high technology will make the clinical allergist a very precise diagnostician.


Subject(s)
Rhinitis, Allergic, Perennial/diagnosis , Rhinitis, Allergic, Perennial/therapy , Rhinitis, Allergic, Seasonal/diagnosis , Rhinitis, Allergic, Seasonal/therapy , Rhinitis/diagnosis , Rhinitis/therapy , Adrenal Cortex Hormones/therapeutic use , Adult , Child , Child, Preschool , Histamine H1 Antagonists/therapeutic use , Humans , Male , Parasympatholytics/therapeutic use , Sympathomimetics/therapeutic use
15.
Am Rev Respir Dis ; 127(5): 575-80, 1983 May.
Article in English | MEDLINE | ID: mdl-6303165

ABSTRACT

We studied the clinical and immunologic features of 10 patients with foreign body granulomatosis associated with injection of pentazocine. Five had typical micronodules on chest radiographs, 9 had abnormal 67Ga lung images, and 9 had elevated serum angiotensin-converting enzyme levels. Pulmonary function tests showed significant decreases in diffusing capacity in 8 subjects, but were otherwise normal. Bronchoalveolar lavage fluid had significantly (p less than 0.02) increased total cell numbers (13.8 +/- 7.5 x 10(7) and significantly lower percentages of lymphocytes (2 +/- 1) and neutrophils (2 +/- 1) (p less than 0.02) when compared with that from control subjects. Peripheral blood lymphocytes were normal when expressed as percentages of total leukocytes or as percent T-lymphocytes. Monoclonal antibody determinations of T-lymphocyte subsets (helper and suppressor) were similar to those in control subjects (p = NS). Lymphocyte transformation responses to a variety of antigens and skin test reactivity were normal. Foreign body granulomatosis contrasts with other interstitial lung diseases in its bronchoalveolar lavage cellular profile and in the absence of altered peripheral immunologic indexes.


Subject(s)
Foreign-Body Reaction/diagnosis , Lung , Pentazocine , Substance-Related Disorders , Adult , Antibodies, Monoclonal , Bronchoscopy , Foreign-Body Reaction/immunology , Gallium Radioisotopes , Humans , Injections, Intravenous , Lung/diagnostic imaging , Lymphocyte Activation , Male , Peptidyl-Dipeptidase A/blood , Pulmonary Diffusing Capacity , Radionuclide Imaging , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Regulatory/immunology , Tablets , Therapeutic Irrigation
16.
Bol. méd. Hosp. Infant. Méx ; 39(4): 273-7, 1982.
Article in Spanish | LILACS | ID: lil-9486

ABSTRACT

En este trabajo se hace un analisis de 207 casos de sindrome coqueluchoide en pacientes atendidos en el Hospital de Infectologia del Centro Medico La Raza del IMSS, de enero de 1978 a agosto de 1980. Se comentan las principales complicaciones observadas, asi como varios aspectos relacionados con: edad, grado de desnutricion, antecedente de contacto con enfermos con tos paroxistica y esquema de vacunacion previo Se hace mencion de la dificultad para obtener cultivos para Bordetella pertussis en cultivo de exudado nasofaringeo


Subject(s)
Infant, Newborn , Infant , Child, Preschool , Child , Humans , Male , Female , Bordetella pertussis , Nutrition Disorders , Whooping Cough
17.
J Pediatr ; 99(1): 68-72, 1981 Jul.
Article in English | MEDLINE | ID: mdl-6265617

ABSTRACT

Serum angiotensin-converting enzyme was measured in 185 children of different ages, in 32 normal adults, in 21 children with sarcoidosis, and in 36 children with other diseases. Children had higher serum ACE volumes than did adults; an intermediate level was absorbed in adolescents. Serum ACE values did not vary according to sex. Children with sarcoidosis had significantly elevated serum ACE levels that closely reflected the activity of the disease. Our results indicate that serum ACE is useful in confirming the diagnosis of sarcoidosis in childhood, and is of greater value as a sensitive indicator for following the course of the disease and the effectiveness of steroid therapy.


Subject(s)
Peptidyl-Dipeptidase A/blood , Sarcoidosis/blood , Adolescent , Adult , Age Factors , Blood Sedimentation , Child , Child, Preschool , Clinical Trials as Topic , Female , Humans , Infant , Infant, Newborn , Lung/diagnostic imaging , Lung/physiopathology , Male , Peptidyl-Dipeptidase A/physiology , Prednisone/therapeutic use , Radiography , Respiratory Function Tests , Sarcoidosis/drug therapy , Sarcoidosis/enzymology , Sarcoidosis/physiopathology
18.
Bol Med Hosp Infant Mex ; 38(1): 103-10, 1981.
Article in Spanish | MEDLINE | ID: mdl-7284060

ABSTRACT

The clinical and laboratory characteristics of eleven cases of bacterial meningitis due to Salmonella, are reviewed. Meningitis was more common in children under the age of 13 months. In younger children the symptoms and neurological signs were not evident. Convulsive disorders and neurological coma were the most frequent complications in 4 and 5 cases respectively. The mortality ratio was high, 36% (4 patients) and the neurological sequelae were very important: two patients presented spastic paralytic alterations and other two had hydrocephalia. The main findings in the cerebral spinal fluid were: increased leukocytes and proteins with low glucose determinations; comparing with other purulent meningitis, mononuclear cells were predominant over polymorphonuclear cells in 7 cases (64%). Salmonella was isolated in all cases; Salmonella typhi was recovered in 3 cases; one had group "C" Salmonella and 7 cases Salmonella group "B". These cases were treated with either chloramphenicol or ampicillin.


Subject(s)
Meningitis/etiology , Salmonella Infections , Adult , Ampicillin/therapeutic use , Cerebrospinal Fluid/microbiology , Chloramphenicol/therapeutic use , Coma/etiology , Female , Humans , Infant , Male , Meningitis/microbiology , Salmonella/isolation & purification , Salmonella Infections/microbiology , Seizures/etiology
20.
JAMA ; 244(15): 1709-11, 1980 Oct 10.
Article in English | MEDLINE | ID: mdl-6997523

ABSTRACT

Rapidly progressive glomerulonephritis developed in a patient with Behçet's syndrome while he was being treated with transfer factor. The therapy did not prevent development of this disease and thus cannot be recommended in patients who have Behçet's syndrome with renal involvement.


Subject(s)
Behcet Syndrome/complications , Glomerulonephritis/etiology , Behcet Syndrome/drug therapy , Biopsy , Clinical Trials as Topic , Double-Blind Method , Female , Glomerulonephritis/pathology , Humans , Immunotherapy , Kidney/pathology , Kidney/ultrastructure , Male , Middle Aged , Transfer Factor/immunology , Transfer Factor/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...